Literature DB >> 7959294

Clear cell adenocarcinoma of the vagina in a young female, treated by combination chemotherapy (local and systemic chemotherapy), complicated with chromosomal abnormality.

H Tanaka1, T Tabata, H Yanase, M Nishiyama, T Yamawaki, H Taniguchi, N Toyoda.   

Abstract

Although cancer of the vagina, a rare form of genital cancer, is usually squamous cell carcinoma in women over the age of 50 years, vaginal clear cell adenocarcinomas (CCA) are exceedingly rare. The pathogenesis of clear cell adenocarcinoma is uncertain, but as a clinical entity, it is most commonly associated with diethylstilbestrol exposure in utero. We report a rare case of primary vaginal CCA in a 17-year-old female who was not exposed to diethylstilbesterol in utero. The case, which was complicated with chromosomal abnormality, was treated with combination chemotherapy. To our knowledge, this is the first reported case of vaginal CCA in a woman with chromosomal abnormality and bicornate uterus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959294     DOI: 10.1006/gyno.1994.1287

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Anterior Pelvic Exenteration for Chemo-irradiated Non-diethylstilbestrol Exposed Clear Cell Vaginal Cancer.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Iulian Brezean
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

2.  Non-diethylstilbestrol exposed vaginal clear cell adenocarcinoma has a common molecular profile with ovarian clear cell adenocarcinoma: A case report.

Authors:  Yuji Ikeda; Katsutoshi Oda; Hiroyuki Aburatani; Kei Kawana; Yutaka Osuga; Tomoyuki Fujii
Journal:  Gynecol Oncol Rep       Date:  2014-06-05

3.  Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature.

Authors:  Mario W Kramer; Mahmoud Abbas; Stefanie Pertschy; Jan Ulrich Becker; Hans-Heinrich Kreipe; Markus A Kuczyk; Axel S Merseburger; Hossein Tezval
Journal:  Rare Tumors       Date:  2012-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.